Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CYTARABINE vs DACOMITINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CYTARABINE vs DACOMITINIB: Safety Overview

Metric CYTARABINE DACOMITINIB
Total FAERS Reports 44,383 682
Deaths Reported 9,089 325
Death Rate 20.5% 47.7%
Hospitalizations 17,861 168
Average Patient Age 38.0 yrs 64.0 yrs
% Female Patients 41.2% 52.0%
FDA Approval Date Approved Prior to Jan 1, 1982 Sep 27, 2018
Manufacturer Sagent Pharmaceuticals Pfizer Laboratories Div Pfizer Inc
Route INTRATHECAL ORAL
Marketing Status Discontinued Prescription